Market Research Report
Nutrigenomics Market: Current Analysis and Forecast (2021-2027)
|Nutrigenomics Market: Current Analysis and Forecast (2021-2027)|
Published: August 1, 2021
UnivDatos Market Insights Pvt Ltd
Content info: 186 Pages
Delivery time: 1-2 business days
Nutrigenomics is a science which comprises testing the DNA and gene samples of entities so that they can be delivered with specially required nutrients, diet and healthcare services. The nutrigenomics market progression is likely to benefit from increasing advances in genomics and molecular biology. The prominent nutrigenomics firms in developed and developing nations provide door to door services, is expected to accelerate the adoption of nutrigenomics during the forecast period. For instance, in July 2019, Nutrigenomix, a global leader in genetic testing for personalized nutrition, had announced the introduction of a detailed dietary analysis and validated online nutrition assessment tool as part of its genetic testing service for healthcare experts and their clients. With this agreement, Nutrigenomix became the first and foremost testing company globally to provide a comprehensive assessment tool to supplement several of its current products and services.
The models of personalized nutrition and precision nutrition permit researchers and nutrition practitioners to tailor individual nutrition necessities better. Nutrigenomics applies many integrative methods concerning high-throughput "omics" technologies such as genomics, transcriptomics, proteomics, metabolomics, metagenomics, and epigenomics. Each analytic platform provides corresponding information that needs to be integrated suitably to achieve a better understanding of the mechanisms underlying nutrition and health. Further the rising heights of research & developments to prevent cases of cancer globally acts as a market driver. For instance, according to the American Cancer Society, In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Further, proper diet nutrition on an individual level may decrease the susceptibility of cancer and hence results in boosting the overall market.
Some of the factors which can hamper the growth of this market include necessity of skilled professionals and physicians to exploit this technology, high cost of treatment with time consuming process, budget limitations for research purposes, and requirement of large investment and resources for the execution of this method will hinder the growth of nutrigenomics market in the forecast period
Since the World Health Organization (WHO) announced that Covid-19 had become a global pandemic, and it has affected almost all the sectors of the market, so it affected the nutrigenomics market as well. But due to increasing cases of Covid 19 most of the population changed their lifestyle and eating habits to adherence with the Mediterranean Diet pattern during the COVID-19 lockdown. For instance, according to a study of PubMed, in June 2020, the perception of weight gain was observed in 48.6% of the population; 3.3% of smokers decided to quit smoking; a slight increased physical activity has been reported, especially for bodyweight training, in 38.3% of respondents; the population group aged 18-30 years resulted in having a higher adherence to the Mediterranean diet when compared to the younger and the elderly population; 15% of respondents turned to farmers or organic, purchasing fruits and vegetables, especially in the North and Center of Italy, where BMI values were lower.
Based on product, the market is bifurcated into reagents & kits and services. The reagents & kits segment grabbed the major market in 2020 due to the surge in demand for ancestry testing, with the use of cheek swabs or saliva DNA test kits, especially in the regions like Europe and North America. For instance, according to the data given by the MIT Institute and Technology, more than 26 million customers had added their respective DNA to four major health databases and commercial ancestry
Based on technique, the market is bifurcated into saliva, buccal swab, blood and others. The saliva segment ruled the major market and accounted for the maximum share in 2020 due to the increasing use of saliva samples for DNA testing globally. This has positively influenced the segment demand in the industry. The healthcare experts collect saliva samples to analyze DNA for genetic variations that affect food and beverage
Based on application, the market is bifurcated into obesity, cardiovascular disorders, diabetes, anti-aging, cancer research, and others. The obesity segment grabbed the major market in 2020 and accounted for the maximum revenue during the forecast period. The increasing obese population is due to the rise in prevalence of lifestyle and eating habits of the population. Further, the nutrigenomics helps in understanding the population on individual gene level and as per the genes, proper nutritious diet will promote reduction in obesity. This innovative approach of nutrigenomics helps in the effective prevention and treatment of diseases and is the key driving factor boosting the growth of this segment.
For a better understanding of the market adoption of nutrigenomics, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for nutrigenomics and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled professionals and physicians.
Moreover, the increasing incidences of cancer, diabetes and obesity are also propelling the nutrigenomics market in this region. For instance, according to Centers for Disease Control and Prevention, 2020, the obesity rates for men are highest for middle-income groups and All the U.S. states and territories have an obesity rate of at least 20%.
Some of the major players operating in the market include: Unilever Group, WellGen Inc., DSM, Metagenics Inc., Nutrigenomix Inc., GX Sciences Inc., BASF SE, Cura Integrative Medicine, Danone, Xcode Life, etc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions
The Nutrigenomics Market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021F to 2027F. The Nutrigenomics Market is expected to witness a boost on account of increasing demand of people towards personalized nutrition and growing diabetic and obese patients across the globe. Also, the rising collaborations between the key industry players will boost the growth of nutrigenomics market